newsfilter
← Latest News
Business Wire·

Aerie Pharmaceuticals Reports Third Quarter 2022 Financial Results

Third Quarter Glaucoma Franchise Net Revenues of $36.1 Million, up 23% over Third Quarter 2021 Previously Announced Agreement to be Acquired by Alcon; Transaction Expected to Close in the Fourth Quarter of 2022 Aerie